June 24, 2022 - A life-changing treatment to reverse injury-related sight loss is now available to patients at specialist centres across England, thanks to a partnership between Newcastle Hospitals and Italian medicines manufacturer, Holostem. The specialist advanced therapy, known as…
Translation of the article by Alberto Greco - published in Il Resto del Carlino Modena, 25 July 2021 While people in Germany, Belgium and Holland were fighting against the devastation caused by the terrible floods of the past few days…
Front Bioeng Biotechnol . 2021 Mar 25;9:652214. doi: 10.3389/fbioe.2021.652214. eCollection 2021. Regenerative Medicine of Epithelia: Lessons From the Past and Future Goals Maurizi E, Adamo D, Magrelli FA, Galaverni G, Attico E, Merra A, Maffezzoni MBR, Losi L, Genna VG,…
Sci Rep. 2020 Aug 14;10(1):13841. doi: 10.1038/s41598-020-70800-w. Surgery Versus ATMPs: An Example From Ophthalmology Magrelli Federica M, Merra A., Pellegrini G. Abstract Advanced therapy medicinal products (ATMPs) are the new frontier of medicine. Advanced therapy medicinal products are set out to…
Cell Prolif. 2019 Nov;52(6):e12653. doi: 10.1111/cpr.12653. Epub 2019 Sep 6. Bioreactor-manufactured cartilage grafts repair acute and chronic osteochondral defects in large animal studies ukasovic A, Asnaghi MA, Kostesic P, Quasnichka H, Cozzolino C, Pusic M, Hails L, Trainor N, Krause C,…
Cary, N.C., and Modena, Italy, June 12, 2018 – Chiesi USA (key-A-zee), a specialty pharmaceutical company based in Cary, N.C., and the Italian biotech Holostem Terapie Avanzate S.r.l., announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug…
Parma/Modena (Italy), February 20, 2015 – The European Commission has granted a conditional marketing authorization, under Regulation (EC) No 726/2004, to Holoclar®, an advanced therapy based on autologous stem cells and capable to restore the eyesight of patients with severe cornea…
